These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 27670353

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC).
    Drilon A, Li G, Dogan S, Gounder M, Shen R, Arcila M, Wang L, Hyman DM, Hechtman J, Wei G, Cam NR, Christiansen J, Luo D, Maneval EC, Bauer T, Patel M, Liu SV, Ou SH, Farago A, Shaw A, Shoemaker RF, Lim J, Hornby Z, Multani P, Ladanyi M, Berger M, Katabi N, Ghossein R, Ho AL.
    Ann Oncol; 2016 May; 27(5):920-6. PubMed ID: 26884591
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic and molecular study including 2 cases harboring ETV6-X fusion.
    Ito Y, Ishibashi K, Masaki A, Fujii K, Fujiyoshi Y, Hattori H, Kawakita D, Matsumoto M, Miyabe S, Shimozato K, Nagao T, Inagaki H.
    Am J Surg Pathol; 2015 May; 39(5):602-10. PubMed ID: 25651470
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The cytological features of mammary analogue secretory carcinoma: a series of 6 molecularly confirmed cases.
    Griffith CC, Stelow EB, Saqi A, Khalbuss WE, Schneider F, Chiosea SI, Seethala RR.
    Cancer Cytopathol; 2013 May; 121(5):234-41. PubMed ID: 23225548
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Clinicopathologic and molecular genetic analysis of secretory carcinoma of salivary gland].
    Zhao M, Zhao DH, Cheng G, Yan YJ, Wang Z, He XL.
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Aug 09; 53(8):533-538. PubMed ID: 30078266
    [Abstract] [Full Text] [Related]

  • 39. Pathological features of mammary analogue secretory carcinoma of the salivary gland.
    Shi K, Lv XQ.
    Int J Clin Exp Pathol; 2017 Aug 09; 10(7):7460-7465. PubMed ID: 31966589
    [Abstract] [Full Text] [Related]

  • 40. Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma.
    Hung YP, Jo VY, Hornick JL.
    Histopathology; 2019 Jul 09; 75(1):54-62. PubMed ID: 30801752
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.